Shalby Ltd - 540797 - Statement Of Investor Complaints For The Quarter Ended June 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0880 Name of the Signatory :- Tushar ShahDesignation :- Company Secretary and Compliance Officer Shalby Ltd - 540797 - Closure of Trading Window
In terms of the provisions of sub-regulation (1) of Regulation 9 of SEBl (Prohibition of lnsider Trading) Regulations, 2015, as amended and trading restrictions placed by the Company''s Code of Conduct to Regulate, Monitor and Reporting of Trading by Insiders ("The Code"), we wish to inform that window for trading in securities of the Company will remain closed from July 01, 2021 till the expiry of 48 hours after the declaration of the Unaudited Financial Results for the quarter ended on June 30,2021 and the trading window shall re-open thereafter. According to the lnsider Trading Code of the Company, all Insiders of the Company have been advised not to trade in the securities of the Company during the aforesaid period of Closure of Trading Window. The lnsider Trading Code of the Company has been made available on the Company''s website i.e. www.shalby.org. Shalby Ltd - 540797 - Announcement under Regulation 30 (LODR)-Investor Presentation
Investor Presentation Shalby Ltd - 540797 - Disclosure Under Regulation 30 Of Sebl LODR
Inauguration of new hospital with new infrastructure facility with 150 beds capacity at Zynova-Shalby, Ghatkopar, West Mumbai. Shalby Ltd - 540797 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Annual Secretarial Compliance Report for financial year ended March 31, 2021 Shalby Ltd - 540797 - Disclosure Of Related Party Transactions On Consolidated Basis For Half Year Ended March 31, 2021 Pursuant To Regulation 23(9) Of Sebl (Listing Obligations And Disclosure Requirements) Regulations, 2015
Pursuant to Regulation 23(9) of the Securities and Exchange Board of lndia (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached disclosure of Related Party Transactions on consolidated basis, in accordance with applicable accounting standards, for the half year ended March 31,2021. Shalby Ltd - 540797 - Transcript Of Conference Call Held On May 18, 2021 To Discuss Recent Acquisition Of Implant Assets From Consensus Orthopedics
With reference to earlier intimation vide our letter no. Shalby/SE/2021-22/26 dated May 17, 2021 and pursuant to Regulation 30 of SEBl (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith transcript of Conference Call held on May 18, 2021 wherein recent Acquisition of Implant Assets from Consensus Orthopedics were discussed. The said transcript is also available in the Investors Section of our website.
Analyst Call for Q4FY21 of Shalby Ltd.
Conference Call with Shalby Management and Analysts on its recent acquisition. Listen to the full transcript. Shalby Ltd - 540797 - Announcement under Regulation 30 (LODR)-Investor Presentation
Acquisition Implant Assets from Consensus Orthopedics Shalby Ltd - 540797 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Schedule of investor Conference call to discuss acquisition announcement of implant assets from Consensus Orthopedics